William Blair downgraded Paragon 28 (FNA) to Market Perform from Outperform without a price target after the company entered into a definitive agreement for Zimmer Biomet to acquire all its outstanding shares for $13.00 in cash, corresponding to an equity value of approximately $1.1B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FNA:
Questions or Comments about the article? Write to editor@tipranks.com